Efficient transfection of MG-63 osteoblasts using magnetic nanoparticles and oscillating magnetic fields

Journal of Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 3, 2014, Pages 169-175

  Fouriki, A ^a   Clements, M A ^b   Farrow, N ^c   Dobson, J ^a,d  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c NanoTherics Limited   (United Kingdom)

^d University of Florida   (United States)

Author keywords

DNA; Magnetic field; Magnetic nanoparticles; Nanomagnetic gene transfection; Non viral gene transfection

Indexed keywords

CELL CULTURE; EFFICIENCY; GENE THERAPY; GENE TRANSFER; MAGNETIC FIELDS; MOLECULAR BIOLOGY; NANOPARTICLES;

CELL/B.E; GENE TRANSFECTION; MAGNETIC-FIELD; NANO-SYSTEMS; NANOMAGNETIC GENE TRANSFECTION; NON-VIRAL GENE TRANSFECTION; NONVIRAL; TRANSFECTION EFFICIENCY; VIRAL GENES;

NANOMAGNETICS;

MAGNETIC NANOPARTICLE;

ARTICLE; CELL VIABILITY; DNA BINDING; ELECTROPORATION; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MAGNETIC FIELD; NONVIRAL GENE DELIVERY SYSTEM; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; REPORTER GENE;

DNA; MAGNETIC FIELD; MAGNETIC NANOPARTICLES; NANOMAGNETIC GENE TRANSFECTION; NON-VIRAL GENE TRANSFECTION;

CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; DNA; ELECTROPORATION; ENDOSOMES; FLOW CYTOMETRY; GENETIC THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; LIPIDS; MAGNETIC FIELDS; MAGNETICS; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; NANOTECHNOLOGY; OSCILLOMETRY; OSTEOBLASTS; TRANSFECTION;

EID: 84895517687     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1508     Document Type: Article

References (31)

1. Alonso V, Gortazar AR, Ardura JA, Andrade-Zapata I, Alvarez-Arroyo MV, Esbrit P. 2008; Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2. J Cell Physiol 217: 717-727.
2. Bhattarai SR, Kim SY, Jang KY, Lee KC, Yi HK, Lee DY, et al. 2008; Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line. J Virol Methods 147: 213-218.
3. Cho HJ, Lee TS, Park JB, Park KK, Choe JY, et al. 2007; Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol 40: 1069-1076.
4. Hsu YL, Kuo PL. 2008; Diosmetin induces human osteoblastic differentiation through the protein kinase c/p38 and extracellular signal-regulated kinase 1/2 pathway. J Bone Miner Res 23: 949-960.
5. Corsi K, Chellat F, L'H Yahia, Fernandes JC. 2003; Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 24: 1255-1264.
6. Dobson J, Batich CD. 2005; Gene delivery, Patent Pending (Application No. WO2006111770).
7. Dobson J. 2006a; Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 13: 283-287.
8. Dobson J. 2006b; Magnetic micro and nano particle based targeting for drug and gene delivery. Nanomedicine 1: 31-37.
9. Fouriki A, Farrow N, Clements M, Dobson J. 2010; Evaluation of the magnetic field requirements for nanomagnetic gene transfection. Nano Reviews 1: 5167, DOI: 10.3402/nano.v1i0.5167.
10. Kersting C, Gebert C, Agelopoulos K, Schmidt H, van Diest PJ, Juergens H, et al. 2007; Epidermal growth factor receptor expression in high-grade osteosarcoma is associated with a good clinical outcome. Clin Cancer Res 13: 2998-3005.
11. Kim SJ, Yoon TJ, Yu KN, Kim BG, Park SJ, Kim HW, et al. 2006; Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 89: 338-347.
12. Klein MJ, Siegal GP. 2006; Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 125: 555-581.
13. Krotz F, Sohn HY, Gloe T, Plank C, Pohl U. 2003; Magnetofection potentiates gene delivery to cultured endothelial cells. J Vasc Res 40: 425-434.
14. Lamoureux F, Richard P, Wittrant Y, Battaglia S, Pilet P, Trichet V, et al. 2007; Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockage of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Res 67: 7308-7318.
15. Liang X, Da M, Zhuang Z, Wu W, Wu Z, Wu Y, et al. 2009; Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro. Cell Biol Int 33: 119-124.
16. Lu Y. 2001; Viral based gene therapy for prostate cancer. Curr Gene Ther 1: 183-200.
17. Mah C, Fraites TJ, Zolotukhin I, Song SH, Flotte TR, Dobson J, et al. 2002; Improved method of recombinant AAV2 delivery for systemic targeted gene delivery. Mol Ther 6: 106-112.
18. Mah C, Zolotukhin I, Fraites TJ, Dobson J, Batich C, Byrne BJ. 2000; Microsphere-mediated delivery of recombinant AVV vectors in vitro and in vivo. Mol Ther 1: S239.
19. McBain SC, Griesenbach U, Xenariou S, Keramane A, Batich CD, Alton EWFW, Dobson J. 2008a; Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. Nanotechnology 19: 405102.
20. McBain SC, Yiu HHP, Dobson J. 2008b; Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 3: 169-180.
21. Mintzer MA, Simanek EE. 2009; Nonviral vectors for gene delivery. Chem Rev 109: 259-302.
22. Muthana M, Scott SD, Farrow N, Morrow F, Murdoch C, Grubb S, Brown R, Dobson J, Lewis CE. 2008; A novel magnetic approach to enhance the efficiency of cell-based gene therapies. Gene Ther 15: 902-910.
23. Pankhurst, QA, Connolly J, Jones SK, Dobson J. 2003; Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 36: R167-R181.
24. Park MR, Han KO, Han IK, Cho MH, Nah JW, Choi YJ, et al. 2005; Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release 105: 367-380.
25. Pickard M, Chari D. 2010; Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields. Nanomedicine 5: 217-232.
26. Plank C, Schillinger U, Scherer F, Bergemann C, Remy JS, Krotz F, et al. 2003; Biological Chemistry, The magnetofection method: using magnetic force to enhance gene delivery. Biol Chem 384: 737-747.
27. Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Krüger A, et al. 2002; Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 9: 102-109.
28. Shi X, Chen A, Cai X, Guo F, Liao G, Ding MA. 2005; Establishment and characterization of cell sublines with high and low metastatic potential derived from human osteosarcoma. C M J 118: 687-690.
29. Spack EG, Sorgi FL. 2001; Developing non-viral DNA delivery systems for cancer and infectious disease. D D T 6: 186-197.
30. Verma IM. 2000; A tumultuous year for gene therapy. Mol Ther 2: 415-416.
31. Zhang Y, Kohler N, Zhang M. 2002; Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23: 1553-1561.